In the current global warming and climate change scenario, clean energy is a hopeful solution. Currently, existing technologies are non-viable due to their inconsistent availability or limited sourcing. In this regard, flow batteries have emerged to be a smaller and cheaper alternative. Researchers at the School of Chemical and Biomolecular Engineering (ChBE), Georgia Institute of Technology, have developed a compact flow battery cell configuration using a hollow sub-millimeter, bundled microtubular (SBMT) membrane as the electrolyte distributor. This membrane, made up of hollow fiber, allows the passing of ions without needing any space-consuming support infrastructure. Their configuration reduces the size of the cell by 75%, thereby reducing the size and cost of the entire flow battery. Their technology has the potential to revolutionize the power systems of commercial buildings and residential homes alike.
Related Posts
Apple Unveils Vision Pro: A Leap into the World of VR, AR, and MR
Apple recently introduced its Vision Pro headset at the Worldwide Developers Conference. The device marks Apple’s entry into the head-mounted devices market, combining virtual reality (VR), augmented reality (AR), and mixed reality (MR) technologies. The Vision Pro allows users to adjust their level of immersion and features an array of cameras, eye-tracking capabilities, and spatial […]
Study Warns Against Opioid Use for Acute Low Back and Neck Pain
A recent Lancet medical journal study reveals that opioids, commonly prescribed for low back and neck pain, provide no significant relief and may worsen pain. The study, involving 347 participants, found opioids did not outperform placebos in pain relief or improve physical function, quality of life, or recovery time. Opioid use resulted in more side […]
First Human Trial of Base Editing for Cholesterol Control Raises Hope and Safety Concerns
Scientists at Verve Therapeutics in Boston conducted the inaugural human trial of base editing, using the treatment VERVE-101 to deactivate the PCSK9 gene in the liver. The gene regulates ‘bad’ cholesterol, and the one-time injection resulted in a significant LDL reduction of up to 55%. This milestone suggests a potential transformative approach to treat coronary […]